Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain Control Following Intravitreal Injection Using Topical Nepefanac 0.3% or Pressure Patching: A Prospective, Randomized, Placebo Controlled Trial

NCT03918590 is registered in ClinicalTrials.gov with The New York Eye & Ear Infirmary as lead sponsor.

NCT NCT03918590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03918590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain Control Following Intravitreal Injection Using Topical Nepefanac 0.3% or Pressure Patching: A Prospective, Randomized, Placebo Controlled Trial
Lead sponsor
The New York Eye & Ear Infirmary
Phase
Phase 4
Overall status
Unknown status
Start date
December 3, 2018
Completion date
June 3, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, neovascular age-related macular degeneration, retinal vein occlusion